Thorough analysis demonstrated that cervical cancer-derived IL-6 drives C/EBPβ-mediated CCL20 induction in cancer-associated fibroblasts and CCL20/CCR6-dependent Th17 recruitment [12]. This evidence concerns the gene CCL20 and cancer.